Related Experiment Video
Updated: Aug 12, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 27, 2016
Natural cyclic depsipeptides and their analogs as potential antimicrobial candidates: mechanistic insight
1Department of Pharmacy, Vidya Vihar, Birla Institute of Technology and Science Pilani, Pilani Campus, Pilani, Rajasthan 333031, India.
Abstract:
Microorganisms such as bacteria, viruses, fungi, and parasites cause serious infections in humans. The misuse of antimicrobial treatments in humans, animals, and agriculture has led to the development of resistant pathogens that can survive and multiply even in the presence of antibiotics. The rise of antibiotic-resistant pathogens has caused significant loss of life and impacted social and economic conditions. Antimicrobial peptides exert antibacterial activity through multiple modes of action. Cyclic peptides are known for greater stability and bioavailability than linear peptides. Among them, cyclic depsipeptides represent a distinct subclass characterized by the presence of an ester bond in addition to peptide bonds. Because of the distinct molecular structure of cyclic depsipeptides, particularly their amino acid components, they demonstrate robust antimicrobial efficacy. Cyclic depsipeptides demonstrate antimicrobial efficacy by targeting various components of the cell wall, including lipid II, menaquinone, lipopolysaccharides, and the DNA polymerase β sliding clamp, as well as by inhibiting biofilm formation and quorum sensing. Additionally, it demonstrated a lower likelihood of resistance development, emphasizing its ability to fight multidrug-resistant pathogens. Given these promising findings, cyclic depsipeptides offer a promising molecular framework for addressing a range of human infections, particularly in an era of increasing antibiotic resistance. This review summarises the recently identified cyclic depsipeptide-based antimicrobial candidates for the treatment of bacterial, fungal, and parasitic infections.
Insights
Cyclic depsipeptides show strong antimicrobial activity against resistant pathogens by targeting cell walls and inhibiting biofilms. These compounds offer a promising new strategy to combat rising antibiotic resistance in human infections.
Area of Science:
- Microbiology
- Biochemistry
- Drug Discovery
Background:
- Antimicrobial resistance is a growing global health threat due to the misuse of antibiotics.
- Pathogens are evolving resistance, leading to increased mortality and socioeconomic impact.
- Antimicrobial peptides (AMPs) offer alternative therapeutic strategies with diverse mechanisms of action.
Purpose of the Study:
- To review recently identified cyclic depsipeptide-based antimicrobial candidates.
- To highlight the potential of cyclic depsipeptides in combating drug-resistant infections.
- To explore the molecular mechanisms underlying their antimicrobial efficacy.
Main Methods:
- Literature review of recent studies on cyclic depsipeptides.
- Analysis of the molecular structures and mechanisms of action of cyclic depsipeptides.
- Evaluation of antimicrobial efficacy against bacterial, fungal, and parasitic pathogens.
Main Results:
- Cyclic depsipeptides exhibit robust antimicrobial efficacy through multiple modes of action.
- They target key cell wall components (e.g., lipid II, menaquinone) and inhibit biofilm formation and quorum sensing.
- These compounds demonstrate a lower likelihood of resistance development compared to traditional antibiotics.
Conclusions:
- Cyclic depsipeptides represent a promising molecular framework for developing novel antimicrobials.
- Their distinct structure and mechanisms offer a viable solution against multidrug-resistant pathogens.
- Further research into cyclic depsipeptides is crucial for addressing the challenge of infectious diseases.
Related Concept Videos
Peptidoglycan Synthesis
Biological Methods for Microbial Control
Gene Regulation in Microbial Communities: Quorum Sensing
Production of Antibiotics
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis

